Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial

Overview of attention for article published in BMC Cancer, May 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 735 followers.

#lcsm #radonc #medonc: Do you give G-CSF during chemoRT for limited stage small cell lung cancer? Dilemma: CONVERT substudy (https://t.co/HIbdMVlcsi) and retrospective data (https://t.co/dFXd9gNHEo) suggest safety, but older data w/toxicity (https://t.co

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.